Cited by 1,255

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2

Wood, David, De Backer, Guy, Faergeman, Ole, Graham, Ian, Mancia, Giuseppe, Pyörälä, Kalevi·1998·Atherosclerosis

DOI 10.1016/s0021-9150(98)90209-x

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s0021-9150(98)90209-x

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

In search of how people change: Applications to addictive behaviors.
Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992) · American Psychologist · doi:10.1037/0003-066x.47.9.1102 · Cited by 8,596
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236

Show all 48 references

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Self-citation
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Self-citation
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Self-citation
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
Self-citation
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score
Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814
Untitled work
Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study
Assmann, G., Cullen, P., & Schulte, H. (2002) · Circulation · doi:10.1161/hc0302.102575 · Cited by 1,541
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations: A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology
Grundy, S. M., Pasternak, R., Greenland, P., Smith, S., & Fuster, V. (1999) · Circulation · doi:10.1161/01.cir.100.13.1481 · Cited by 1,315
Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women
Hu, G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1066 · Cited by 1,135
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology
Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science · doi:10.1042/cs20000335 · Cited by 1,084
Untitled work
Greenland (2000) · doi:10.1161/01.cir.101.1.e16 · Cited by 924
Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme
(2001) · European Heart Journal · doi:10.1053/euhj.2001.2610 · Cited by 893
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men
Ridker, P. M., Paynter, N. P., Rifai, N., Gaziano, J. M., & Cook, N. R. (2008) · Circulation · doi:10.1161/circulationaha.108.814251 · Cited by 841
Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries
Kotseva, K., Wood, D., De Backer, G., De Bacquer, D., Pyörälä, K., & Keil, U. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60330-5 · Cited by 833
Self-citation
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
Kotseva, K., Wood, D., Backer, G. D., Bacquer, D. D., Pyörälä, K., Keil, U., & EUROASPIRE Study Group (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283294b1d · Cited by 812
Self-citation
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
Self-citation
Cardiovascular Risk Prediction: Basic Concepts, Current Status, and Future Directions
Lloyd-Jones, D. M. (2010) · Circulation · doi:10.1161/circulationaha.109.849166 · Cited by 705
Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?
Ridker, P. M., Wilson, P. W. F., & Grundy, S. M. (2004) · Circulation · doi:10.1161/01.cir.0000132467.45278.59 · Cited by 645
Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial
Wood, D., Kotseva, K., Connolly, S., Jennings, C., Mead, A., Jones, J., Holden, A., De Bacquer, D., Collier, T., De Backer, G., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60868-5 · Cited by 601
Self-citation
Framingham risk score and prediction of lifetime risk for coronary heart disease
Lloyd-Jones, D. M., Wilson, P. W. F., Larson, M. G., Beiser, A., Leip, E. P., D'Agostino, R. B., & Levy, D. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.023 · Cited by 566
Expert consensus document on ?-adrenergic receptor blockersThe Task Force on Beta-Blockers of the European Society of Cardiology
(2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.002 · Cited by 557
Self-citation
The Relation between Blood Pressure and Mortality Due to Coronary Heart Disease among Men in Different Parts of the World
van den Hoogen, P. C. W., Feskens, E. J. M., Nagelkerke, N. J. D., Menotti, A., Nissinen, A., & Kromhout, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001063420101 · Cited by 552
Untitled work
Kothari (2002) · doi:10.1161/01.str.0000020091.07144.c7 · Cited by 420
Low intake of fruits, berries and vegetables is associated with excess mortality in men: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study
Rissanen, T. H., Voutilainen, S., Virtanen, J. K., Venho, B., Vanharanta, M., Mursu, J., & Salonen, J. T. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.1.199 · Cited by 260
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology
Pappolla, M. A., Bryant-Thomas, T. K., Herbert, D., Pacheco, J., Fabra Garcia, M., Manjon, M., Girones, X., Henry, T. L., Matsubara, E., Zambon, D., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000070182.02537.84 · Cited by 247
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
Kotseva, K., Wood, D., De Backer, G., De Bacquer, D., Pyörälä, K., Reiner, Ž., Keil, U., & EUROASPIRE Study Group (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283383f30 · Cited by 238
Self-citation
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation
Ferrario, M., Chiodini, P., Chambless, L. E., Cesana, G., Vanuzzo, D., Panico, S., Sega, R., Pilotto, L., Palmieri, L., & Giampaoli, S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyh405 · Cited by 214
Pharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials.
Pousinho, S., Morgado, M., Falcão, A., & Alves, G. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.22.5.493 · Cited by 199
Framingham-based tools to calculate the global risk of coronary heart disease: A systematic review of tools for clinicians
Sheridan, S., Pignone, M., & Mulrow, C. (2003) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2003.30107.x · Cited by 178
Average Volume of Alcohol Consumption, Patterns of Drinking and Risk of Coronary Heart Disease - A Review
Rehm, J., Sempos, C. T., & Trevisan, M. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670301000104 · Cited by 164
Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey
Reiner, Ž., Sonicki, Z., & Tedeschi-Reiner, E. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.09.014 · Cited by 148
Effectiveness of individual lifestyle interventions in reducing cardiovascular disease and risk factors
Ketola, E., Sipilä, R., & Mäkelä, M. (2000) · Annals of Medicine · doi:10.3109/07853890009011767 · Cited by 135
Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients.
Lins, R. L., Matthys, K. E., Verpooten, G. A., Peeters, P. C., Dratwa, M., Stolear, J.-C., & Lameire, N. H. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg048 · Cited by 128
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
Packard, C. J., Ford, I., Robertson, M., Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L. E. M., Buckley, B. M., Cobbe, S. M., Gaw, A., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.526848 · Cited by 121
Impact of wearable physical activity monitoring devices with exercise prescription or advice in the maintenance phase of cardiac rehabilitation: systematic review and meta-analysis
Hannan, A. L., Harders, M. P., Hing, W., Climstein, M., Coombes, J. S., & Furness, J. (2019) · BMC Sports Science, Medicine and Rehabilitation · doi:10.1186/s13102-019-0126-8 · Cited by 119
Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin
Kosoglou, T., Meyer, I., Veltri, E. P., Statkevich, P., Yang, B., Zhu, Y., Mellars, L., Maxwell, S. E., Patrick, J. E., Cutler, D. L., et al. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01633.x · Cited by 117
Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-year Chinese Multi-Provincial Cohort Study (CMCS)
Ren, J., Grundy, S. M., Liu, J., Wang, W., Wang, M., Sun, J., Liu, J., Li, Y., Wu, Z., & Zhao, D. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.020 · Cited by 111
Patients' ideas, fears and expectations of their coronary risk: barriers for primary prevention
van Steenkiste, B., van der Weijden, T., Timmermans, D., Vaes, J., Stoffers, J., & Grol, R. (2004) · Patient Education and Counseling · doi:10.1016/j.pec.2003.11.005 · Cited by 117
Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy
Benner, J. S., Tierce, J. C., Ballantyne, C. M., Prasad, C., Bullano, M. F., Willey, V. J., Erbey, J., & Sugano, D. S. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422003-00003 · Cited by 115
Effect of alcohol on risk of coronary heart disease and stroke: causality, bias, or a bit of both?
Emberson, J. R., & Bennett, D. A. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.239 · Cited by 99
C-Reactive Protein, Diabetes, and Attendance at Religious Services
King, D. E., Mainous, A. G., & Pearson, W. S. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1172 · Cited by 105
Barriers to implementing cardiovascular risk tables in routine general practice
Steenkiste, B. V., Weijden, T. V. D., Stoffers, H. E. J. H., & Grol, R. (2004) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430310004489 · Cited by 104
Serum Total and Non-High-Density Lipoprotein Cholesterol and the Risk Prediction of Cardiovascular Events: – The JALS-ECC –
Tanabe, N., Iso, H., Okada, K., Nakamura, Y., Harada, A., Ohashi, Y., Ando, T., Ueshima, H., & The Japan Arteriosclerosis Longitudinal Study Group (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0861 · Cited by 99
Serum Lipid Survey and Its Recent Trend in the General Japanese Population in 2000
Arai, H., Yamamoto, A., Matsuzawa, Y., Saito, Y., Yamada, N., Oikawa, S., Mabuchi, H., Teramoto, T., Sasaki, J., Nakaya, N., et al. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.98 · Cited by 94
Effects of the mediterranean diet on the components of metabolic syndrome concerning the cardiometabolic risk
Scaglione, S., Di Chiara, T., Daidone, M., & Tuttolomondo, A. (2025) · Nutrients · doi:10.3390/nu17020358 · Cited by 92
The safety of HMG-CoA reductase inhibitors in special populations at high cardiovascular risk
Corsini, A. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1026132412074 · Cited by 82
Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients
Franceschini, G., Calabresi, L., Colombo, C., Favari, E., Bernini, F., & Sirtori, C. R. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.10.017 · Cited by 66
Parity and Carotid Atherosclerosis in Men and Women: Insights Into the Roles of Childbearing and Child-Rearing
Skilton, M. R., Sérusclat, A., Begg, L. M., Moulin, P., & Bonnet, F. (2009) · Stroke · doi:10.1161/strokeaha.108.535807 · Cited by 62
Nebivolol vs Amlodipine as First-line Treatment of Essential Arterial Hypertension in the Elderly
Mazza, A., Gil-Extremera, B., Maldonato, A., Toutouzas, T., & Pessina, A. C. (2002) · Blood Pressure · doi:10.1080/080370502760050421 · Cited by 57
Statins for primary prevention of cardiovascular disease
Byrne, P., Cullinan, J., & Smith, S. M. (2019) · BMJ · doi:10.1136/bmj.l5674 · Cited by 53
Educational inequalities in blood pressure and cholesterol screening in nine European countries
Rodin, D., Stirbu, I., Ekholm, O., Dzurova, D., Costa, G., Mackenbach, J. P., & Kunst, A. E. (2012) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2011-200273 · Cited by 26
Lowering LDL cholesterol in adults: a prospective, community-based practice initiative
Coodley, G. O., Jorgensen, M., Kirschenbaum, J., Sparks, C., Zeigler, L., & Albertson, B. D. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.02.031 · Cited by 23
Exploring gender and socioeconomic differences in treatment of coronary heart disease
Manderbacka, K. (2005) · European Journal of Public Health · doi:10.1093/eurpub/cki050 · Cited by 17

Authors: Wood, D., De Backer, G., Faergeman, O., Graham, I., Mancia, G., & Pyörälä, K.
Venue: Atherosclerosis
Publisher: Elsevier BV
Published: 1998-10
Volume: 140
Issue: 2
Pages: 199-270
ISSN: 0021-9150 (ISSN-L)
DOI: 10.1016/s0021-9150(98)90209-x
OpenAlex: W1499548788
Cited by: 1,255
References: 48
FWCI: 88.04
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review